Centessa Pharmaceuticals plc ( CNTA) - Stock Earnings
Stock symbol CNTA is outdated, potentially delisted? Maybe it is available on other exchange?
CNTA Upcoming earnings
Estimated EPS and revenue columns are available to paid members.
| Date | EPS (actual / est.) | Revenue low (est.) | Revenue (actual / est.) | Revenue high (est.) |
|---|---|---|---|---|
| Aug. 11, 2026, midnight | — / — | — | — / — | — |
CNTA Quarterly earnings
Analyst consensus estimates are available to paid members.
| Date | Earnings | Revenue |
|---|---|---|
| 2025Q3 | -54.9 million USD | — USD |
| 2025Q4 | -66.2 million USD | — USD |
| 2026Q1 | -79.2 million USD | — USD |
| 2026Q3 Est. | — | — |
| 2026Q4 Est. | — | — |
CNTA Yearly earnings
Analyst consensus estimates are available to paid members.
| Date | Earnings | Revenue |
|---|---|---|
| 2023 | -151.1 million USD | 6.9 million USD |
| 2024 | -235.8 million USD | — USD |
| 2025 | -197.5 million USD | 15.0 million USD |
| 2026 Est. | — | — |
CNTA
Price: $40.50
52 week price:
Earnings Per Share: -1.78 USD
Exchange: NMS
Sector: Healthcare
Industry: Biotechnology
Country: United Kingdom
Volume: 66900
Market Capitalization: 6.2 billion